Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer

Minetta C. Liu, Peter G. Shields, Robert Warren, +8

Journal of Clinical Oncology

The Relation between Estrogen Receptors and Response Rate to Cytotoxic Chemotherapy in Metastatic Breast Cancer

Marc E. Lippman, Joseph C. Allegra, E. Brad Thompson, +7

New England Journal of Medicine

Estrogen ReceptorsMetastatic Breast CancerOncologyBreast OncologyMedicine +11

Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer

Joseph C. Allegra, Marc E. Lippman, E. Brad Thompson, +7

European Journal of Cancer (1965)

Metastatic Breast CancerOncologyImportant VariableBreast OncologyMedicine +8

A Comparison of Efficacy of Sargramostim (Yeast-Derived RhuGM-CSF) and Filgrastim (Bacteria-Derived RhuG-CSF) in the Therapeutic Setting of Chemotherapy-Induced Myelosuppression

Roy Beveridge, John A. Miller, Arthur N. Kales, +40

Cancer Investigation

Membrane transport of methotrexate in human lymphoblastoid cells.

Robert Warren, Arlene P. Nichols, Richard A. Bender

PubMed

Mtx ConcentrationCell CultureCellular PharmacologyCellular PhysiologyTranslational Pharmacology +17

Abnormal Pulmonary Gallium Accumulation in<i>P. Carinii</i>Pneumonia

Stanley Μ. Levenson, Robert Warren, Steven D. Richman, +2

Radiology

Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer

Claudine Isaacs, Pia Herbolsheimer, Minetta C. Liu, +10

Breast Cancer Research and Treatment

Breast OncologyOncologyPhase I/ii StudyMedicineBreast Cancer +6

Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy

Roy Beveridge, John A. Miller, Arthur N. Kales, +22

Supportive Care in Cancer

Hematological MalignancyBacteria-derived Rhug-csfMedicineClinical TrialsPathology +8

Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function

Katia Khoury, Filipa Lynce, Ana Barac, +15

Breast Cancer Research and Treatment

Compromised Heart FunctionBreast OncologyCardiovascular DiseaseMedicineCardiac Safety +7

Breaking Down Barriers to Breast and Cervical Cancer Screening: A University-based Prevention Program for Latinas

Anne Y. Warren, Gloria E Londoño, Lois Wessel, +1

Journal of Health Care for the Poor and Underserved